We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DLA
751
DELISTED
Delta Apparel Inc.
DLA
| $210K | 0.03% |
+10,965
| New | +$169K |
|
|
MRLN
752
DELISTED
Marlin Business Services Corp
MRLN
| $210K | 0.03% |
+14,645
| New | +$210K |
|
|
OB
753
DELISTED
Onebeacon Insurance Group Ltd
OB
| $209K | 0.03% |
+16,450
| New | +$210K |
|
754
INNOVATE Corp
VATE
$116M
| $208K | 0.03% |
5,447
+4,235
| +349% | +$163K |
|
755
Gran Tierra Energy
GTE
$238M
| $207K | 0.03% |
8,386
-6,003
| -42% | -$139K |
|
|
HZN
756
DELISTED
Horizon Global Corporation
HZN
| $207K | 0.03% |
+16,480
| New | +$163K |
|
|
TTP
757
DELISTED
TORTOISE PIPELINE & ENERGY FUND, INC.
TTP
| $207K | 0.03% |
3,505
-3,251
| -48% | -$166K |
|
|
FFIC
758
DELISTED
Flushing Financial
FFIC
| $206K | 0.03% |
+9,547
| New | +$199K |
|
759
Coherent
COHR
$53.1B
| $205K | 0.03% |
9,438
-144,984
| -94% | -$2.88M |
|
760
ESCO Technologies
ESE
$8.4B
| $205K | 0.03% |
5,263
-12,668
| -71% | -$448K |
|
|
SAND
761
DELISTED
Sandstorm Gold
SAND
| $205K | 0.03% |
62,229
+12,618
| +25% | +$34.7K |
|
|
REV
762
DELISTED
Revlon, Inc.
REV
| $205K | 0.03% |
+5,636
| New | +$177K |
|
|
SWZ
763
Swiss Helvetia Fund
SWZ
$76.2M
| $204K | 0.03% |
+20,011
| New | +$198K |
|
764
DXP Enterprises
DXPE
$2.57B
| $203K | 0.03% |
+11,557
| New | +$189K |
|
|
STEW
765
SRH Total Return Fund
STEW
$1.76B
| $203K | 0.03% |
25,820
+10,349
| +67% | +$74.8K |
|
|
MAGN
766
Magnera Corp
MAGN
$490M
| $203K | 0.03% |
755
-7,380
| -91% | -$1.67M |
|
767
Interparfums
IPAR
$3.99B
| $202K | 0.03% |
6,549
-32,658
| -83% | -$853K |
|
|
NMO
768
DELISTED
NUVEEN MUNI MARKET OPPORT FUND
NMO
| $202K | 0.03% |
+14,197
| New | +$199K |
|
769
Peapack-Gladstone Financial
PGC
$833M
| $201K | 0.03% |
+11,919
| New | +$216K |
|
770
Emcor
EME
$33B
| $200K | 0.03% |
+4,120
| New | +$188K |
|
771
Varonis Systems
VRNS
$5.36B
| $200K | 0.03% |
+32,862
| New | +$193K |
|
|
LADR
772
Ladder Capital
LADR
$1.24B
| $199K | 0.03% |
+16,107
| New | +$178K |
|
773
Radiant Logistics
RLGT
$415M
| $197K | 0.03% |
+55,281
| New | +$183K |
|
|
EMO
774
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.06B
| $194K | 0.03% |
3,445
-3,655
| -51% | -$182K |
|
|
RSYS
775
DELISTED
Radisys Corp
RSYS
| $194K | 0.03% |
+49,234
| New | +$144K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.